389 related articles for article (PubMed ID: 32183808)
1. An integrative review on the information and communication needs of parents of children with cancer regarding the use of complementary and alternative medicine.
Stub T; Kristoffersen AE; Overvåg G; Jong MC
BMC Complement Med Ther; 2020 Mar; 20(1):90. PubMed ID: 32183808
[TBL] [Abstract][Full Text] [Related]
2. Communication and information needs about complementary and alternative medicine: a qualitative study of parents of children with cancer.
Stub T; Quandt SA; Kristoffersen AE; Jong MC; Arcury TA
BMC Complement Med Ther; 2021 Mar; 21(1):85. PubMed ID: 33685422
[TBL] [Abstract][Full Text] [Related]
3. Parents' experiences of information-seeking and decision-making regarding complementary medicine for children with autism spectrum disorder: a qualitative study.
Smith CA; Parton C; King M; Gallego G
BMC Complement Med Ther; 2020 Jan; 20(1):4. PubMed ID: 32020887
[TBL] [Abstract][Full Text] [Related]
4. Development of an evidence-based decision aid on complementary and alternative medicine (CAM) and pain for parents of children with cancer.
Jong MC; Boers I; van Wietmarschen H; Busch M; Naafs MC; Kaspers GJL; Tissing WJE
Support Care Cancer; 2020 May; 28(5):2415-2429. PubMed ID: 31493135
[TBL] [Abstract][Full Text] [Related]
5. KOKON: A Germany-Wide Collaborative Research Project to Identify Needs, Provide Information, Foster Communication and Support Decision-Making about Complementary and Alternative Medicine in Oncology.
Güthlin C; Bartsch HH; Joos S; Längler A; Lampert C; Ritter C; Schildmann J; Weis J; Wilhelm M; Witt CM; Horneber M
Complement Med Res; 2020; 27(2):105-111. PubMed ID: 31722354
[TBL] [Abstract][Full Text] [Related]
6. Information needs and usage of complementary and alternative medicine in members of a German self-help group for gastrointestinal stroma tumours, sarcoma, and renal cancer.
Bauer F; Schmidt T; Eisfeld H; Dubois C; Kastrati K; Hochhaus A; Huebner J
Complement Ther Med; 2018 Dec; 41():105-110. PubMed ID: 30477825
[TBL] [Abstract][Full Text] [Related]
7. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
[TBL] [Abstract][Full Text] [Related]
8. Pattern and predictors of complementary and alternative medicine (CAM) use among pediatric patients with epilepsy.
Doering JH; Reuner G; Kadish NE; Pietz J; Schubert-Bast S
Epilepsy Behav; 2013 Oct; 29(1):41-6. PubMed ID: 23933629
[TBL] [Abstract][Full Text] [Related]
9. The experience of adults who choose watchful waiting or active surveillance as an approach to medical treatment: a qualitative systematic review.
Rittenmeyer L; Huffman D; Alagna M; Moore E
JBI Database System Rev Implement Rep; 2016 Feb; 14(2):174-255. PubMed ID: 27536798
[TBL] [Abstract][Full Text] [Related]
10. Assessing the role of evidence in patients' evaluation of complementary therapies: a quality study.
Verhoef MJ; Mulkins A; Carlson LE; Hilsden RJ; Kania A
Integr Cancer Ther; 2007 Dec; 6(4):345-53. PubMed ID: 18048882
[TBL] [Abstract][Full Text] [Related]
11. Decision-making about complementary and alternative medicine by cancer patients: integrative literature review.
Weeks L; Balneaves LG; Paterson C; Verhoef M
Open Med; 2014; 8(2):e54-66. PubMed ID: 25009685
[TBL] [Abstract][Full Text] [Related]
12. Interventions for promoting participation in shared decision-making for children with cancer.
Coyne I; O'Mathúna DP; Gibson F; Shields L; Leclercq E; Sheaf G
Cochrane Database Syst Rev; 2016 Nov; 11(11):CD008970. PubMed ID: 27898175
[TBL] [Abstract][Full Text] [Related]
13. Critical Review of Complementary and Alternative Medicine Use in Amyotrophic Lateral Sclerosis: Prevalence and Users' Profile, Decision-Making, Information Seeking, and Disclosure in the Face of a Lack of Efficacy.
Adams J; Lee M; Peng W
Neurodegener Dis; 2018; 18(4):225-232. PubMed ID: 30248676
[TBL] [Abstract][Full Text] [Related]
14. Complementary and alternative medicine (CAM) use in advanced cancer: a systematic review.
Truant TL; Porcino AJ; Ross BC; Wong ME; Hilario CT
J Support Oncol; 2013 Sep; 11(3):105-13. PubMed ID: 24400390
[TBL] [Abstract][Full Text] [Related]
15. Complementary and alternative medicine use by pediatric oncology patients before, during, and after treatment.
Lüthi E; Diezi M; Danon N; Dubois J; Pasquier J; Burnand B; Rodondi PY
BMC Complement Med Ther; 2021 Mar; 21(1):96. PubMed ID: 33736643
[TBL] [Abstract][Full Text] [Related]
16. High prevalence of complementary and alternative medicine use in the Dutch pediatric oncology population: a multicenter survey.
Singendonk M; Kaspers GJ; Naafs-Wilstra M; Meeteren AS; Loeffen J; Vlieger A
Eur J Pediatr; 2013 Jan; 172(1):31-7. PubMed ID: 22991098
[TBL] [Abstract][Full Text] [Related]
17. Critical review of complementary and alternative medicine use in menopause: focus on prevalence, motivation, decision-making, and communication.
Peng W; Adams J; Sibbritt DW; Frawley JE
Menopause; 2014 May; 21(5):536-48. PubMed ID: 24104604
[TBL] [Abstract][Full Text] [Related]
18. Decisions to use complementary and alternative medicine (CAM) by male cancer patients: information-seeking roles and types of evidence used.
Evans M; Shaw A; Thompson EA; Falk S; Turton P; Thompson T; Sharp D
BMC Complement Altern Med; 2007 Aug; 7():25. PubMed ID: 17683580
[TBL] [Abstract][Full Text] [Related]
19. Open dialogue about complementary and alternative medicine (CAM) integrated in conventional oncology care, characteristics and impact. A systematic review.
Stie M; Jensen LH; Delmar C; Nørgaard B
Patient Educ Couns; 2020 Nov; 103(11):2224-2234. PubMed ID: 32563705
[TBL] [Abstract][Full Text] [Related]
20. 'Thinking outside the box': complementary and alternative therapies use in paediatric oncology patients.
Molassiotis A; Cubbin D
Eur J Oncol Nurs; 2004 Mar; 8(1):50-60. PubMed ID: 15003744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
